Comparison
2q13 Microdeletion Syndrome C6012360 vs 12q15q21 1 Microdeletion Syndrome C4518344
Clinical comparison between 2q13 Microdeletion Syndrome and 12q15q21 1 Microdeletion Syndrome for differential diagnosis and treatment planning.
2q13 Microdeletion Syndrome C6012360
A rare genetic condition where a small piece of chromosome 2 is missing. It can affect development and cause distinctive features. Care involves multiple specialists based on symptoms.
12q15q21 1 Microdeletion Syndrome C4518344
A rare chromosomal deletion affecting a portion of chromosome 12. Presentation varies and may include developmental concerns and medical issues. Treatment addresses specific symptoms with a multidisciplinary approach.
6 comparison axes
Onset
2q13 Microdeletion Syndrome C6012360
Variable
12q15q21 1 Microdeletion Syndrome C4518344
0-0
Onset patterns differ
Severity
2q13 Microdeletion Syndrome C6012360
severe
12q15q21 1 Microdeletion Syndrome C4518344
moderate
Different severity levels
Chronic
2q13 Microdeletion Syndrome C6012360
Chronic
12q15q21 1 Microdeletion Syndrome C4518344
Chronic
Differing course
Communicable
2q13 Microdeletion Syndrome C6012360
No
12q15q21 1 Microdeletion Syndrome C4518344
No
Different transmission
Body System
2q13 Microdeletion Syndrome C6012360
congenital
12q15q21 1 Microdeletion Syndrome C4518344
congenital
Same/different system
Category
2q13 Microdeletion Syndrome C6012360
rare-disease
12q15q21 1 Microdeletion Syndrome C4518344
genetic
Different category
Bottom line
2q13-microdeletion-syndrome-C6012360 and 12q15q21-1-microdeletion-syndrome-C4518344 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2q13 Microdeletion Syndrome C6012360 | 12q15q21 1 Microdeletion Syndrome C4518344 | Discriminating power |
|---|---|---|---|
| Developmental concerns | Development may be affected; no specific pattern is supplied. | Developmental concerns may occur; pattern is not established. | Low |
| Physical or medical features | Distinctive features are mentioned but not specified. | Variable medical issues are mentioned without a defined pattern. | Low |
| Severity label | Supplied severity is severe, not an individual prognosis. | Supplied severity is moderate, with variable presentation. | Moderate |
When to favor each condition
Choose 2q13 Microdeletion Syndrome C6012360 when
Testing confirms a deletion involving 2q13.
The chromosome locus matches the left concept.
High
Metadata are used only for broad severity context.
The source labels it severe, but personal outcome is unknown.
Moderate
Reported onset is variable rather than a fixed age.
Variable onset is the supplied left value.
Low
Choose 12q15q21 1 Microdeletion Syndrome C4518344 when
Testing confirms a 12q15q21.1 deletion.
The named chromosome segment matches the right concept.
High
Presentation is variable and severity metadata say moderate.
This aligns with the supplied right description and label.
Moderate
The supplied onset value is 0-0.
This value is not a clear clinical age and needs interpretation.
Low
How key tests differ
| Test | 2q13 Microdeletion Syndrome C6012360 | 12q15q21 1 Microdeletion Syndrome C4518344 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Deletion involving 2q13 when confirmed. | Deletion involving 12q15q21.1 when confirmed. | Locus separates the concepts; a genetics clinician should interpret significance. |
| Standard karyotype | A small deletion may not be detected. | A small deletion may not be detected. | A normal karyotype does not exclude either microdeletion. |
| Symptom-directed assessments | Selected according to individual findings. | Selected according to individual findings. | Abnormal results are findings, not independently diagnostic of either syndrome. |
Prognosis comparison
2q13 Microdeletion Syndrome C6012360
- Outcome
- Long-term outcome is not established; source severity is severe.
- Factors
- Confirmed locus, gene content, and individual findings, none detailed here.
12q15q21 1 Microdeletion Syndrome C4518344
- Outcome
- Outcome is not established; source severity is moderate and variable.
- Factors
- Deletion extent and symptom burden, with specifics not supplied.
Time frame: Both are described as chronic; no exact timeline is established.
Genetic confirmation, developmental needs, and associated medical findings require clinician interpretation.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental complications | Possible, but type and frequency are not supplied. Possible, but type and frequency are not supplied. Do not infer a specific developmental diagnosis from the syndrome name alone. |
| Congenital anomalies | Congenital classification is supplied; anomalies are unspecified. Congenital classification is supplied; anomalies are unspecified. Evaluation should follow observed findings rather than an assumed checklist. |
| Overall medical burden | Labeled severe in the source. Labeled moderate in the source. These labels do not establish individual complications or mortality. |
Patient education highlights
- HighConfirmation
A named syndrome should be confirmed by appropriate genetic testing and clinician review.
- HighTransmission
Neither condition is communicable; the supplied data do not support person-to-person spread.
- MediumCare planning
Care is multidisciplinary and symptom-based. No standard dose or treatment is established here.